Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Sell
34
WST Quote, Financials, Valuation and Earnings
Last price:
$205.29
Seasonality move
:
3.44%
Day range:
$209.81 - $213.34
52-week range:
$187.43 - $372.52
Dividend yield:
0.39%
P/E ratio:
33.12x
P/S ratio:
5.35x
P/B ratio:
5.65x
Volume:
439.3K
Avg. volume:
977.6K
1-year change:
-42.2%
Market cap:
$15.2B
Revenue:
$2.9B
EPS (TTM):
$6.37
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.8B | $2.9B | $2.9B | $2.9B | |
| Revenue Growth (YoY) | 16.69% | 31.89% | 1.95% | 2.18% | -1.92% | |
| Cost of Revenues | $1.4B | $1.7B | $1.8B | $1.8B | $1.9B | |
| Gross Profit | $767.8M | $1.2B | $1.1B | $1.1B | $998.5M | |
| Gross Profit Margin | 35.76% | 41.52% | 39.36% | 38.28% | 34.51% | |
| R&D Expenses | $46.9M | $52.8M | $58.5M | $68.4M | $69.1M | |
| Selling, General & Admin | $302M | $362.8M | $316.9M | $353.4M | $338.5M | |
| Other Inc / (Exp) | -$10.8M | -$4.1M | -$78.1M | -$28.4M | -$22M | |
| Operating Expenses | $348.9M | $415.6M | $375.4M | $421.8M | $407.6M | |
| Operating Income | $418.9M | $760.2M | $760.8M | $707.4M | $590.9M | |
| Net Interest Expenses | $6.8M | $7.2M | $2.8M | -- | -- | |
| EBT. Incl. Unusual Items | $401.3M | $748.9M | $679.9M | $698M | $585.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $72.5M | $107.2M | $114.7M | $122.3M | $107.5M | |
| Net Income to Company | $346.2M | $661.8M | $585.9M | $593.4M | $492.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $346.2M | $661.8M | $585.9M | $593.4M | $492.7M | |
| Basic EPS (Cont. Ops) | $4.68 | $8.89 | $7.87 | $7.98 | $6.75 | |
| Diluted EPS (Cont. Ops) | $4.57 | $8.67 | $7.73 | $7.88 | $6.69 | |
| Weighted Average Basic Share | $73.9M | $74.4M | $74.4M | $74.3M | $73M | |
| Weighted Average Diluted Share | $75.8M | $76.3M | $75.8M | $75.3M | $73.7M | |
| EBITDA | $518.6M | $879.4M | $808.4M | $844.3M | $743.9M | |
| EBIT | $409.5M | $757.1M | $687.8M | $707M | $588.5M | |
| Revenue (Reported) | $2.1B | $2.8B | $2.9B | $2.9B | $2.9B | |
| Operating Income (Reported) | $418.9M | $760.2M | $760.8M | $707.4M | $590.9M | |
| Operating Income (Adjusted) | $409.5M | $757.1M | $687.8M | $707M | $588.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $670.7M | $720M | $716.6M | $695.4M | $698M | |
| Revenue Growth (YoY) | 36.46% | 7.35% | -0.47% | -2.96% | 0.37% | |
| Cost of Revenues | $398.8M | $435.4M | $445.3M | $465.2M | $466.1M | |
| Gross Profit | $271.9M | $284.6M | $271.3M | $230.2M | $231.9M | |
| Gross Profit Margin | 40.54% | 39.53% | 37.86% | 33.1% | 33.22% | |
| R&D Expenses | $12.2M | $14.6M | $17.1M | $17.6M | $16.3M | |
| Selling, General & Admin | $80.2M | $83.4M | $86M | $86.7M | $88M | |
| Other Inc / (Exp) | -$2.8M | $3.1M | -$12.9M | -$3.1M | -$20.8M | |
| Operating Expenses | $92.4M | $98M | $103.1M | $104.3M | $104.3M | |
| Operating Income | $179.5M | $186.6M | $168.2M | $125.9M | $127.6M | |
| Net Interest Expenses | $1.8M | $1.9M | -- | -- | -- | |
| EBT. Incl. Unusual Items | $174.9M | $187.8M | $157.9M | $127.4M | $110.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $28.7M | $21.2M | $23.6M | $16.4M | $24.1M | |
| Net Income to Company | $151.2M | $173.8M | $140M | $115.3M | $89.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $151.2M | $173.8M | $140M | $115.3M | $89.8M | |
| Basic EPS (Cont. Ops) | $2.04 | $2.34 | $1.88 | $1.57 | $1.24 | |
| Diluted EPS (Cont. Ops) | $1.99 | $2.29 | $1.85 | $1.55 | $1.23 | |
| Weighted Average Basic Share | $73.9M | $74.4M | $74.5M | $73.5M | $72.5M | |
| Weighted Average Diluted Share | $75.8M | $76M | $75.7M | $74.3M | $73M | |
| EBITDA | $205.9M | $219.6M | $191.7M | $164.6M | $150.9M | |
| EBIT | $176.8M | $190M | $160.1M | $129M | $110.9M | |
| Revenue (Reported) | $670.7M | $720M | $716.6M | $695.4M | $698M | |
| Operating Income (Reported) | $179.5M | $186.6M | $168.2M | $125.9M | $127.6M | |
| Operating Income (Adjusted) | $176.8M | $190M | $160.1M | $129M | $110.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | $2.9B | $2.9B | $2.9B | $2.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.5B | $1.7B | $1.8B | $1.8B | $1.9B | |
| Gross Profit | $872.7M | $1.2B | $1.1B | $1.1B | $1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $48.4M | $55.2M | $61M | $68.9M | $67.8M | |
| Selling, General & Admin | $310.4M | $366M | $319.5M | $354.1M | $339.8M | |
| Other Inc / (Exp) | -$16.8M | $1.8M | -$94.1M | -$18.6M | -$39.7M | |
| Operating Expenses | $358.8M | $421.2M | $380.5M | $423M | $407.6M | |
| Operating Income | $513.9M | $767.3M | $742.4M | $665.1M | $592.6M | |
| Net Interest Expenses | $7.4M | $7.3M | -- | -- | -- | |
| EBT. Incl. Unusual Items | $489.7M | $761.8M | $650M | $667.5M | $568.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $86.2M | $99.7M | $117.1M | $115.1M | $115.2M | |
| Net Income to Company | $423.1M | $684.4M | $552.1M | $568.7M | $467.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $423.1M | $684.4M | $552.1M | $568.7M | $467.2M | |
| Basic EPS (Cont. Ops) | $5.72 | $9.22 | $7.41 | $7.67 | $6.42 | |
| Diluted EPS (Cont. Ops) | $5.58 | $9.00 | $7.28 | $7.58 | $6.37 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $610M | $893.1M | $780.5M | $817.2M | $730.2M | |
| EBIT | $497.8M | $770.3M | $657.9M | $675.9M | $570.4M | |
| Revenue (Reported) | $2.3B | $2.9B | $2.9B | $2.9B | $2.9B | |
| Operating Income (Reported) | $513.9M | $767.3M | $742.4M | $665.1M | $592.6M | |
| Operating Income (Adjusted) | $497.8M | $770.3M | $657.9M | $675.9M | $570.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $670.7M | $720M | $716.6M | $695.4M | $698M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $398.8M | $435.4M | $445.3M | $465.2M | $466.1M | |
| Gross Profit | $271.9M | $284.6M | $271.3M | $230.2M | $231.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.2M | $14.6M | $17.1M | $17.6M | $16.3M | |
| Selling, General & Admin | $80.2M | $83.4M | $86M | $86.7M | $88M | |
| Other Inc / (Exp) | -$2.8M | $3.1M | -$12.9M | -$3.1M | -$20.8M | |
| Operating Expenses | $92.4M | $98M | $103.1M | $104.3M | $104.3M | |
| Operating Income | $179.5M | $186.6M | $168.2M | $125.9M | $127.6M | |
| Net Interest Expenses | $1.8M | $1.9M | -- | -- | -- | |
| EBT. Incl. Unusual Items | $174.9M | $187.8M | $157.9M | $127.4M | $110.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $28.7M | $21.2M | $23.6M | $16.4M | $24.1M | |
| Net Income to Company | $151.2M | $173.8M | $140M | $115.3M | $89.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $151.2M | $173.8M | $140M | $115.3M | $89.8M | |
| Basic EPS (Cont. Ops) | $2.04 | $2.34 | $1.88 | $1.57 | $1.24 | |
| Diluted EPS (Cont. Ops) | $1.99 | $2.29 | $1.85 | $1.55 | $1.23 | |
| Weighted Average Basic Share | $73.9M | $74.4M | $74.5M | $73.5M | $72.5M | |
| Weighted Average Diluted Share | $75.8M | $76M | $75.7M | $74.3M | $73M | |
| EBITDA | $205.9M | $219.6M | $191.7M | $164.6M | $150.9M | |
| EBIT | $176.8M | $190M | $160.1M | $129M | $110.9M | |
| Revenue (Reported) | $670.7M | $720M | $716.6M | $695.4M | $698M | |
| Operating Income (Reported) | $179.5M | $186.6M | $168.2M | $125.9M | $127.6M | |
| Operating Income (Adjusted) | $176.8M | $190M | $160.1M | $129M | $110.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $615.5M | $762.6M | $894.3M | $853.9M | $484.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $385.3M | $489M | $507.4M | $512M | $552.5M | |
| Inventory | $321.3M | $378.4M | $414.8M | $434.7M | $377M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $51.6M | $112M | $103M | $135.8M | $124M | |
| Total Current Assets | $1.4B | $1.7B | $1.9B | $1.9B | $1.5B | |
| Property Plant And Equipment | $1B | $1.1B | $1.3B | $1.5B | $1.7B | |
| Long-Term Investments | $214.7M | $207.7M | $204.9M | $210M | $202.1M | |
| Goodwill | $111.1M | $109.9M | $107.3M | $108.5M | $106.1M | |
| Other Intangibles | $30.5M | $23M | $18.4M | $15.1M | $10.8M | |
| Other Long-Term Assets | $23.4M | $39.2M | $38.4M | $21.3M | $74.3M | |
| Total Assets | $2.8B | $3.3B | $3.6B | $3.8B | $3.6B | |
| Accounts Payable | $213.1M | $232.2M | $215.4M | $242.4M | $239.3M | |
| Accrued Expenses | $123M | $161.9M | $116.8M | $136M | $106.5M | |
| Current Portion Of Long-Term Debt | $2.3M | $44.2M | $2.2M | $134M | -- | |
| Current Portion Of Capital Lease Obligations | $10.1M | $9.3M | $16M | $17.7M | $17.9M | |
| Other Current Liabilities | $31.4M | $29.3M | $32.1M | $39.5M | $57.4M | |
| Total Current Liabilities | $503.4M | $594.1M | $519M | $671.8M | $550.4M | |
| Long-Term Debt | $252.9M | $208.8M | $206.7M | $72.8M | $202.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $939.3M | $978.4M | $931.9M | $948.5M | $961.1M | |
| Common Stock | $18.8M | $18.8M | $18.8M | $18.8M | $18.8M | |
| Other Common Equity Adj | -$110.6M | -$159.6M | -$183M | -$143.8M | -$258.1M | |
| Common Equity | $1.9B | $2.3B | $2.7B | $2.9B | $2.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.9B | $2.3B | $2.7B | $2.9B | $2.7B | |
| Total Liabilities and Equity | $2.8B | $3.3B | $3.6B | $3.8B | $3.6B | |
| Cash and Short Terms | $615.5M | $762.6M | $894.3M | $853.9M | $484.6M | |
| Total Debt | $255.2M | $253M | $208.9M | $206.8M | $202.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $483.7M | $667.7M | $886.3M | $601.8M | $404.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $465.7M | $498.7M | $513.4M | $524M | $543.6M | |
| Inventory | $310.2M | $416.5M | $447M | $429.9M | $388.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $67.4M | $107.6M | $90.5M | $137.2M | $121M | |
| Total Current Assets | $1.3B | $1.7B | $1.9B | $1.7B | $1.5B | |
| Property Plant And Equipment | $995.3M | $1.1B | $1.3B | $1.5B | $1.7B | |
| Long-Term Investments | $211.9M | $208.1M | $208.8M | $202.5M | $211.9M | |
| Goodwill | $109.5M | $108.8M | $107.8M | $107.6M | $107.5M | |
| Other Intangibles | $28.7M | $21.8M | $17.8M | $13.9M | $10M | |
| Other Long-Term Assets | $24.8M | $40.5M | $36.7M | $19M | $70.2M | |
| Total Assets | $2.7B | $3.3B | $3.7B | $3.6B | $3.6B | |
| Accounts Payable | $204.3M | $248.2M | $233.8M | $240.1M | $228.4M | |
| Accrued Expenses | $69.9M | $77.5M | $65.7M | $66.5M | $67.8M | |
| Current Portion Of Long-Term Debt | $2.3M | $44.2M | $2.2M | $133.4M | -- | |
| Current Portion Of Capital Lease Obligations | $9.4M | $9.8M | $16.2M | $18M | $21.8M | |
| Other Current Liabilities | $144.8M | $168M | $158M | $173.6M | $186.4M | |
| Total Current Liabilities | $482.8M | $584.8M | $534.9M | $648.4M | $526.7M | |
| Long-Term Debt | $252.3M | $208.3M | $206.1M | $72.8M | $202.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $910.7M | $968.5M | $947.4M | $921.7M | $935.1M | |
| Common Stock | $18.8M | $18.8M | $18.8M | $18.8M | $18.8M | |
| Other Common Equity Adj | -$140.2M | -$182.4M | -$168.4M | -$192.3M | -$205.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.8B | $2.3B | $2.8B | $2.7B | $2.7B | |
| Total Liabilities and Equity | $2.7B | $3.3B | $3.7B | $3.6B | $3.6B | |
| Cash and Short Terms | $483.7M | $667.7M | $886.3M | $601.8M | $404.2M | |
| Total Debt | $254.6M | $252.5M | $208.3M | $206.2M | $202.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $346.2M | $661.8M | $585.9M | $593.4M | $492.7M | |
| Depreciation & Amoritzation | $109.1M | $122.3M | $120.6M | $137.3M | $155.4M | |
| Stock-Based Compensation | $34M | $37.5M | $23.7M | $23.3M | $18.7M | |
| Change in Accounts Receivable | -$46.6M | -$123.5M | -$35.6M | $4M | -$58.8M | |
| Change in Inventories | -$73.7M | -$86.5M | -$49.8M | -$13.5M | $42M | |
| Cash From Operations | $472.5M | $584M | $724M | $776.5M | $653.4M | |
| Capital Expenditures | $174.4M | $253.4M | $284.6M | $362M | $377M | |
| Cash Acquisitions | -- | -$2.2M | -- | -- | -- | |
| Cash From Investing | -$179.5M | -$253.1M | -$288.2M | -$368.7M | -$378.7M | |
| Dividends Paid (Ex Special Dividend) | -$48.1M | -$51.1M | -$54.1M | -$57M | -$59.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $164.7M | |
| Long-Term Debt Repaid | -$2.3M | -$2.2M | -$44.3M | -$2.4M | -$192.3M | |
| Repurchase of Common Stock | -$121.4M | -$151.9M | -$222.2M | -$451.2M | -$566.6M | |
| Other Financing Activities | -- | -- | -$1.2M | -- | -$2M | |
| Cash From Financing | -$137.1M | -$168.1M | -$293.6M | -$459.6M | -$622.6M | |
| Beginning Cash (CF) | $439.1M | $615.5M | $762.6M | $894.3M | $853.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $155.9M | $162.8M | $142.2M | -$51.8M | -$347.9M | |
| Ending Cash (CF) | $615.5M | $762.6M | $894.3M | $853.9M | $484.6M | |
| Levered Free Cash Flow | $298.1M | $330.6M | $439.4M | $414.5M | $276.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $151.2M | $173.8M | $140M | $115.3M | $89.8M | |
| Depreciation & Amoritzation | $29.1M | $29.6M | $31.6M | $35.6M | $40M | |
| Stock-Based Compensation | $5.9M | $5.5M | $8.5M | $5M | $1.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $88.7M | $151.2M | $138.1M | $118.2M | $129.4M | |
| Capital Expenditures | $54.7M | $65.8M | $82.1M | $90.6M | $71.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$54.5M | -$68.3M | -$82.1M | -$90.6M | -$71.3M | |
| Dividends Paid (Ex Special Dividend) | -$12.6M | -$13.4M | -$14.1M | -$14.7M | -$15.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$600K | -$600K | -$600K | -$700K | -$200K | |
| Repurchase of Common Stock | -$150.8M | -$165.9M | -$71.6M | -$272.4M | -$136M | |
| Other Financing Activities | -- | -$1.1M | -- | -$100K | -- | |
| Cash From Financing | -$156.4M | -$172.7M | -$71M | -$271M | -$147M | |
| Beginning Cash (CF) | $615.5M | $762.6M | $894.3M | $853.9M | $484.6M | |
| Foreign Exchange Rate Adjustment | -$9.6M | -$5.1M | $7M | -$8.7M | $8.5M | |
| Additions / Reductions | -$122.2M | -$89.8M | -$15M | -$243.4M | -$88.9M | |
| Ending Cash (CF) | $483.7M | $667.7M | $886.3M | $601.8M | $404.2M | |
| Levered Free Cash Flow | $34M | $85.4M | $56M | $27.6M | $58.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $423.1M | $684.4M | $552.1M | $568.7M | $467.2M | |
| Depreciation & Amoritzation | $112.2M | $122.8M | $122.6M | $141.3M | $159.8M | |
| Stock-Based Compensation | $34.5M | $37.1M | $26.7M | $19.8M | $15M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $504.1M | $646.5M | $710.9M | $756.6M | $664.6M | |
| Capital Expenditures | $197M | $264.5M | $300.9M | $370.5M | $357.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$202.1M | -$266.9M | -$302M | -$377.2M | -$359.4M | |
| Dividends Paid (Ex Special Dividend) | -$48.9M | -$51.9M | -$54.8M | -$57.6M | -$59.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2.3M | -$2.2M | -$44.3M | -$2.5M | -$191.8M | |
| Repurchase of Common Stock | -$155.5M | -$167M | -$127.9M | -$652M | -$430.2M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$173.2M | -$184.4M | -$191.9M | -$659.6M | -$498.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $128.8M | $195.2M | $217M | -$280.2M | -$193.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $307.1M | $382M | $410M | $386.1M | $306.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $151.2M | $173.8M | $140M | $115.3M | $89.8M | |
| Depreciation & Amoritzation | $29.1M | $29.6M | $31.6M | $35.6M | $40M | |
| Stock-Based Compensation | $5.9M | $5.5M | $8.5M | $5M | $1.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $88.7M | $151.2M | $138.1M | $118.2M | $129.4M | |
| Capital Expenditures | $54.7M | $65.8M | $82.1M | $90.6M | $71.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$54.5M | -$68.3M | -$82.1M | -$90.6M | -$71.3M | |
| Dividends Paid (Ex Special Dividend) | -$12.6M | -$13.4M | -$14.1M | -$14.7M | -$15.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$600K | -$600K | -$600K | -$700K | -$200K | |
| Repurchase of Common Stock | -$150.8M | -$165.9M | -$71.6M | -$272.4M | -$136M | |
| Other Financing Activities | -- | -$1.1M | -- | -$100K | -- | |
| Cash From Financing | -$156.4M | -$172.7M | -$71M | -$271M | -$147M | |
| Beginning Cash (CF) | $615.5M | $762.6M | $894.3M | $853.9M | $484.6M | |
| Foreign Exchange Rate Adjustment | -$9.6M | -$5.1M | $7M | -$8.7M | $8.5M | |
| Additions / Reductions | -$122.2M | -$89.8M | -$15M | -$243.4M | -$88.9M | |
| Ending Cash (CF) | $483.7M | $667.7M | $886.3M | $601.8M | $404.2M | |
| Levered Free Cash Flow | $34M | $85.4M | $56M | $27.6M | $58.1M | |
Get WST Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
WST
Sector
P/E ratio
33.12x
24.03x
PEG ratio
18.00x
0.00x
P/B ratio
5.65x
1.68x
Price / LTM sales
5.35x
1.61x
Growth Metrics
WST
Sector
Revenue growth
0.37%
5.64%
Earnings growth
-20.65%
7.69%
Revenue (5-year growth)
9.48%
8.27%
Earnings forecast
$1.26
-$0.20
Profitability
WST
Sector
Profitability FY 2024
$998.5M
$54.2M
Return on invested capital
16.23%
-14.62%
Return on assets
12.96%
-11.9%
Return on equity
17.47%
-17.27%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Jul
25
Estimated Next Earnings Date
Jul
24
Balance Sheet
WST
Sector
Total cash
$404.2M
$40.4M
Short term investments
--
$34.9M
Total assets
$3.6B
$120.5M
Long term debt
$202.6M
$9.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
